We understand the challenges in liquid biopsy, from achieving high sensitivity and accuracy to standardizing workflows. That's why our experts Alexandra Sommer and Niklas Iffländer will share how our award-winning and patented technology, the Phase Separator™, can deliver up to double the speed of camera-based system for phase separation. Accelerate your liquid biopsy workflows with our Liquid Biopsy portfolio solutions. Register now at https://lnkd.in/eSfrf_H5
Tecan
Biotechnologieforschung
Männedorf, ZH 53.653 Follower:innen
Scaling healthcare innovation globally.
Info
At Tecan we are driven to improve people’s lives and health. We do this by empowering our customers to scale healthcare innovation globally from life science to the clinic. We collaborate with our customers in healthcare and the life sciences, from early-stage innovation through project implementation and beyond. We deliver the products, services and solutions that make lab processes and medical procedures precise, reproducible and compliant. This leads to scalable outcomes that are further reaching and ever more valuable to humankind.
- Website
-
http://www.tecan.com
Externer Link zu Tecan
- Branche
- Biotechnologieforschung
- Größe
- 1.001–5.000 Beschäftigte
- Hauptsitz
- Männedorf, ZH
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Spezialgebiete
- Laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics, clinical diagnostics, biopharmaceuticals , laboratory automation, biotechnology, genetics, OEM, life science, research, medtech, liquid handling, laboratory equipment , mass spectrometry , biomarkers , drug discovery, cell biology , Immunoassays , diagnostics , analytical chemistry , immunodiagnostics und IVD
Orte
Beschäftigte von Tecan
Updates
-
Delve deeper into the innovation behind MedTech development with the second blog of our three-part series by Tecan’s technology development group, Emphysys. Following our introduction to the transformative ‘Rapid Solution Blueprint’, a strategic science-based strategy for developing medical devices, this blog focuses on its first two segments: 'Literature Review' and 'Phenomena to Understand.' These foundational elements are crucial for navigating the complex landscape of medical device innovation and solving critical challenges with unprecedented efficiency. This blog illustrates the practical application of these strategies in the face of adversity, highlighting the Emphysys 'fail fast discovery' method that significantly shortens the time from concept to market-ready solutions. Read the full blog at the link below to learn more about the science-driven tactics that empower Emphysys engineers to turn intricate problems into optimized outcomes and gain further insight with our exclusive infographic on the Emphysys Rapid Solution framework. Read the full blog here: https://lnkd.in/dFTdfVMk #MedTechInnovation #RapidIdeation #TechnologyDevelopment #MedicalEngineering
-
-
PCR-based tests are essential for identifying diseases, but manual processing is slow and error-prone. Certest Biotec, S.L., in partnership with Tecan, has developed VIASURE V-Flex, an automated, flexible solution transforming infectious disease testing. This cutting-edge innovation enables labs to run multiple PCR reactions on a single plate, significantly boosting efficiency. It's particularly advantageous for smaller labs that don’t require large-scale testing. Attending the ADLM conference in Chicago? Stop by Tecan’s booth #3810 to see VIASURE V-Flex in action and discover why Tecan is your strategic OEM partner. Learn more about how this solution is advancing diagnostic technology: https://lnkd.in/dDAfDjag #PCRTesting #Diagnostics #LabEfficiency #InfectiousDiseases #Tecan #CertestBiotec
-
-
𝐓𝐡𝐚𝐧𝐤 𝐲𝐨𝐮 𝐭𝐨 𝐞𝐯𝐞𝐫𝐲𝐨𝐧𝐞 𝐰𝐡𝐨 𝐩𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝 𝐢𝐧 𝐓𝐞𝐜𝐚𝐧 𝐆𝐢𝐯𝐞𝐬 𝐁𝐚𝐜𝐤 2024! Over 750 of our colleagues participated in Tecan's fundraising month. Congratulations to all who took part in the activities supporting better physical and mental health. Your dedication makes a difference. This year we proudly donate to the Swiss Cancer Foundation and European Liquid Biopsy Society (ELBS), the conservation charity World Land Trust and CDH International - the World's Oldest. Largest, and Leading Congenital Diaphragmatic Hernia Charity. #CorporateResponsibility #Fundraising #TecanGivesBack #Sustainability
-
-
Discover how spatial biology is revolutionizing our understanding of cellular interactions and disease mechanisms. From visualizing molecules in 3D to mapping gene regulation in tumor microenvironments, spatial omics opens new doors for diagnostics and therapies. Learn more about the latest techniques in spatial transcriptomics, proteomics, and more. Dive into the details in our latest blog post: https://lnkd.in/dfmqUNmi #SpatialBiology #Research #Innovation #Diagnostics
-
-
Join Tecan experts Matt Bugas, Fabio Maretto and Cyrille Andrianoff for an in-depth webinar on how our Phase Separator™ Technology can streamline blood fractionation and biobanking applications. Learn how pressure monitoring technology can enhance efficiency, save time and improve sample tracking in your lab. #Webinar #Biobanking #Automation #LabEfficiency #BloodFractionation #PhaseSeparator #Tecan
Rethink your blood fractionation workflows with Phase Separator™
www.linkedin.com
-
Dive into the dynamic world of flow cytometry, where precision meets possibility. This powerful technique allows for detailed analysis of cell characteristics, empowering researchers to conduct complex immunophenotyping, cell sorting and much more. Sysmex Corporation, a leader in diagnostics and laboratory solutions, has developed, in partnership with Tecan, an automated sample preparation system for flow cytometry (FCM). The latest Tecan Journal article showcases this successful partnership, including its global product expansion. Read the full story online: https://lnkd.in/ggZbEWzC #Tecan #OEM #flowcytometry #healthcarejourney
-
-
𝐀𝐧 𝐞𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐧𝐞𝐰 𝐜𝐡𝐚𝐩𝐭𝐞𝐫 𝐟𝐨𝐫 𝐓𝐞𝐜𝐚𝐧'𝐬 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬! We are pleased to announce Mukta Acharya as the new Head of Tecan's Life Sciences Business division and a member of the Management Board. She is expected to take up her new position on August 1, 2024. Mukta, currently President of Tecan Americas, has driven significant growth in our US business. Her extensive industry experience, including senior roles at Thermo Fisher Scientific and CVS Health, make her the ideal leader to take our business to the next level. We also thank Klaus Lun for his contribution during his years with Tecan and wish him the very best in his future endeavors. Join us in congratulating Mukta as we look forward to the exciting next steps for Tecan’s Life Sciences Business! #LifeSciences #Tecan #ScalingHealthcareInnovationGlobally
-
-
Are you struggling with the costs and complexities of chemical synthesis in drug discovery? Our liquid handling automation platform Fluent® has been adapted by our integration group, Labwerx, to deal with the challenges associated with chemical synthesis. It can safely handle and pipette organic solvents such as Tetrahydrofuran (THF) or Dimethyl sulfoxide (DMSO). Using our technology, customers have successfully executed synthetic reactions using inert gas atmospheres. Our innovation reduces expenses and waste by miniaturizing reaction volumes, making use of Fluent’s precise liquid handling system. Explore how automation can boost innovation in your lab by reaching out to us: https://lnkd.in/drV9BWZg #LabAutomation #DrugDiscovery #ChemicalSynthesis
-
-
The In-Vitro Diagnostic Regulation (IVDR) is significantly affecting the in vitro diagnostic landscape and is highly relevant to laboratories using their own in-house testing (LDTs). As a professional managing LDTs, you know how challenging it can be to find relevant information and understand the impact of the IVDR on your lab. Register for our webinar, "Making sense of IVDR for LC-MS," hosted on SelectScience on June 26, and learn more about the following topics: • What is IVDR and what are the timelines? • Requirements for in-house tests (LDTs). • Next steps for your lab. Don't miss this opportunity to stay ahead and ensure your lab's compliance with the latest regulations. Register here: https://lnkd.in/dxpR4w_Q #lcms #IVDR #Tecan
New IVDR Regulations: Impact on LC-MS/MS Labs Using LDTs Get insights on how the EU's new In Vitro Diagnostic Regulation (IVDR) affects labs running in-house LC-MS/MS tests (LDTs). This webinar is for you if: ➡️You use LC-MS/MS for Laboratory Developed Tests (LDTs) ➡️You're unsure about the IVDR's impact on your lab Register here: https://lnkd.in/eWAjUwVb #IVDR #LCMSMS #LDTs #InVitroDiagnostics Tecan
-